The results of the four scenarios were:
(1) screening by cytology followed by colposcopic assessment for cytologic report of AGUS/CIN1 or more severe; eight CIN2+ lesions would be detected at a cost of $17.98 per screened woman or $6,743 per detected CIN2+ lesion;
(2) screening by cytology followed by colposcopic assessment for cytologic report of AGUS/CIN1 or more severe, or in case of persistent ASCUS at repeat smear; cost of $19.4 per screened woman or $5,291 per detected CIN2+ lesion;
(3) screening by colposcopy followed by cytology in cases with evidence of condyloma at punch biopsy; all CIN2+ lesions would be detected at a cost of $23.86 per screened woman or $3,977 per detected CIN2+ lesion;
(4) screening by colposcopy alone; sixteen CIN2+ lesions would be detected at a cost of $22.1 per screened woman or $4,144 per detected CIN2+ lesion.